{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-004686","form_type":"8-K/A","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2022-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.116144+00:00","generated_at":"2026-06-27T03:56:59.767212+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ultralife files audited Excell financials: $18.5M sales, $1.5M net income for Feb-Dec 2021 stub","bullets":["Sales $18.46M, gross profit $4.32M (23.4% margin), net income $1.49M for period Feb 1-Dec 12, 2021.","Total assets $9.0M, equity $6.45M; cash $736K, accounts receivable $3.57M, inventory $3.44M.","Auditor MNP LLP issued qualified opinion unable to audit opening inventory affecting cost of sales.","Company paid $4.78M dividends and repaid $729K shareholder advances during stub period.","Acquisition closed Dec 13, 2021; financials now filed via Form 8-K/A."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-004686","json":"https://secwatch.observer/filing/0001437749-22-004686.json","markdown":"https://secwatch.observer/filing/0001437749-22-004686.md","text":"https://secwatch.observer/filing/0001437749-22-004686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774922004686/0001437749-22-004686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774922004686/ulbi20220228_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T03:56:59.767212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}